UBcare. Co. Ltd
UBcare. Co., Ltd. provides health care solutions in South Korea and internationally. The company offers medical IT services, such as Ysarang, an EMR system for hospital/clinic use; and U Pharm, an integrated management control system for pharmacies, hospitals, clinics, and pharmacy environments; and Big Ysarang, an EMR system for small and medium-sized hospitals, as well as customer management an… Read more
UBcare. Co. Ltd (032620) - Total Liabilities
Latest total liabilities as of September 2025: ₩72.26 Billion KRW
Based on the latest financial reports, UBcare. Co. Ltd (032620) has total liabilities worth ₩72.26 Billion KRW as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
UBcare. Co. Ltd - Total Liabilities Trend (2011–2024)
This chart illustrates how UBcare. Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
UBcare. Co. Ltd Competitors by Total Liabilities
The table below lists competitors of UBcare. Co. Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Lincoln Pharmaceuticals Limited
NSE:LINCOLN
|
India | ₹1.39 Billion |
|
Cox Energy América, S.A.B. de C.V.
MC:COXE
|
Spain | €10.33 Billion |
|
Wieson Technologies Co Ltd
TWO:6272
|
Taiwan | NT$2.52 Billion |
|
Cabral Gold Inc
PINK:CBGZF
|
USA | $1.78 Million |
|
Americas Car-Mart Inc
NASDAQ:CRMT
|
USA | $1.16 Billion |
|
Sunjuice Holdings Co Ltd
TW:1256
|
Taiwan | NT$1.17 Billion |
|
Ucloudlink Group Inc
NASDAQ:UCL
|
USA | $39.41 Million |
Liability Composition Analysis (2011–2024)
This chart breaks down UBcare. Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.81 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.50 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.31 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how UBcare. Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for UBcare. Co. Ltd (2011–2024)
The table below shows the annual total liabilities of UBcare. Co. Ltd from 2011 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩60.85 Billion | +46.76% |
| 2023-12-31 | ₩41.46 Billion | -8.24% |
| 2022-12-31 | ₩45.18 Billion | +44.02% |
| 2021-12-31 | ₩31.37 Billion | -34.14% |
| 2020-12-31 | ₩47.63 Billion | +39.39% |
| 2019-12-31 | ₩34.17 Billion | +20.84% |
| 2018-12-31 | ₩28.28 Billion | +25.47% |
| 2017-12-31 | ₩22.54 Billion | +23.47% |
| 2016-12-31 | ₩18.25 Billion | -3.63% |
| 2015-12-31 | ₩18.94 Billion | +42.60% |
| 2014-12-31 | ₩13.28 Billion | +19.15% |
| 2013-12-31 | ₩11.15 Billion | -25.72% |
| 2012-12-31 | ₩15.01 Billion | +58.05% |
| 2011-12-31 | ₩9.50 Billion | -- |